Free Trial

Beta Bionics (BBNX) News Today

Beta Bionics logo
$10.48 +0.02 (+0.19%)
As of 04:00 PM Eastern
Beta Bionics to Host Investor Event on June 22, 2025
Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus
BBNX Beta Bionics, Inc.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What Happened
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What Happened
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Stock Price Up 2.8% - Here's What Happened
Beta Bionics (NASDAQ:BBNX) Shares Up 2.8% - What's Next?
Beta Bionics welcomes new board member Gerard Michel
Beta Bionics, Inc. stock logo
Q1 EPS Estimates for Beta Bionics Reduced by Leerink Partnrs
Beta Bionics, Inc. (NASDAQ:BBNX - Free Report) - Investment analysts at Leerink Partnrs lowered their Q1 2025 EPS estimates for shares of Beta Bionics in a research note issued on Wednesday, March 26th. Leerink Partnrs analyst M. Kratky now forecasts that the company will earn ($0.51) per share f
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Stock Price Down 3% - Here's Why
Beta Bionics (NASDAQ:BBNX) Trading Down 3% - Should You Sell?
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Hits New 52-Week Low After Earnings Miss
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low After Earnings Miss
Beta Bionics reports Q4 EPS ($2.72), consensus ($1.22)
Beta Bionics, Inc. (BBNX) Gets a Buy from Piper Sandler
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Announces Earnings Results
Beta Bionics (NASDAQ:BBNX - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($1.40).
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Trading Down 3% - What's Next?
Beta Bionics (NASDAQ:BBNX) Shares Down 3% - Here's What Happened
Beta Bionics, Inc. stock logo
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from Analysts
Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) has received an average rating of "Moderate Buy" from the nine brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Shares Up 7.1% - Here's Why
Beta Bionics (NASDAQ:BBNX) Shares Up 7.1% - Here's What Happened
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Reaches New 52-Week Low - Time to Sell?
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What Happened
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Shares Down 6.6% - Here's Why
Beta Bionics (NASDAQ:BBNX) Shares Down 6.6% - What's Next?
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Hits New 52-Week Low - Should You Sell?
Beta Bionics (NASDAQ:BBNX) Reaches New 52-Week Low - Should You Sell?
Beta Bionics, Inc. stock logo
Beta Bionics, Inc.'s Quiet Period Will Expire on March 11th (NASDAQ:BBNX)
Beta Bionics' (NASDAQ:BBNX - Get Free Report) quiet period will expire on Tuesday, March 11th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. During Beta Bionics' quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Hits New 52-Week Low - Here's Why
Beta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - Time to Sell?
Beta Bionics, Inc. stock logo
Leerink Partnrs Weighs in on Beta Bionics FY2024 Earnings
Beta Bionics, Inc. (NASDAQ:BBNX - Free Report) - Investment analysts at Leerink Partnrs issued their FY2024 earnings per share estimates for shares of Beta Bionics in a research report issued on Monday, February 24th. Leerink Partnrs analyst M. Kratky forecasts that the company will post earnings
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Upgraded to Strong-Buy at Leerink Partnrs
Leerink Partnrs upgraded Beta Bionics to a "strong-buy" rating in a research report on Monday.
Beta Bionics initiated with an Outperform at Leerink
Beta Bionics initiated with a Buy at BofA
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Earns Buy Rating from Analysts at Bank of America
Bank of America initiated coverage on shares of Beta Bionics in a research note on Monday. They issued a "buy" rating on the stock.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Coverage Initiated at Lake Street Capital
Lake Street Capital began coverage on Beta Bionics in a report on Monday. They issued a "buy" rating and a $30.00 price objective on the stock.
Beta Bionics, Inc. stock logo
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Hold" by Analysts
Shares of Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) have been assigned an average recommendation of "Hold" from the three brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating. The average 12 month price
Beta Bionics, Inc. stock logo
Stifel Nicolaus Initiates Coverage on Beta Bionics (NASDAQ:BBNX)
Stifel Nicolaus began coverage on Beta Bionics in a research note on Monday. They issued a "buy" rating and a $25.00 target price for the company.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Earns Overweight Rating from Analysts at Piper Sandler
Piper Sandler started coverage on shares of Beta Bionics in a research report on Monday. They set an "overweight" rating and a $26.00 price objective for the company.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Coverage Initiated at Leerink Partners
Leerink Partners initiated coverage on shares of Beta Bionics in a research report on Monday. They set an "outperform" rating and a $28.00 price objective on the stock.
Beta Bionics, Inc. stock logo
Baird R W Upgrades Beta Bionics (NASDAQ:BBNX) to "Hold"
Baird R W upgraded shares of Beta Bionics to a "hold" rating in a research note on Thursday.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - What's Next?
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Time to Sell?
Beta Bionics, Inc. stock logo
LADENBURG THALM/SH SH Begins Coverage on Beta Bionics (NASDAQ:BBNX)
LADENBURG THALM/SH SH began coverage on Beta Bionics in a research note on Thursday. They set a "neutral" rating and a $20.00 target price for the company.
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Now Covered by Robert W. Baird
Robert W. Baird started coverage on shares of Beta Bionics in a report on Thursday. They issued a "neutral" rating and a $20.00 price objective for the company.
Beta Bionics initiated with a Buy at Ladenburg
Beta Bionics initiated with a Neutral at Baird
Beta Bionics Inc BBNX
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - Time to Sell?
Beta Bionics (NASDAQ:BBNX) Reaches New 12-Month Low - Here's What Happened
Beta Bionics, Inc. stock logo
Beta Bionics (NASDAQ:BBNX) Stock Price Down 5.7% - Should You Sell?
Beta Bionics (NASDAQ:BBNX) Stock Price Down 5.7% - Here's Why
Remove Ads
Get Beta Bionics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter.

BBNX Media Mentions By Week

BBNX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BBNX
News Sentiment

0.96

0.78

Average
Medical
News Sentiment

BBNX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BBNX Articles
This Week

2

4

BBNX Articles
Average Week

Remove Ads
Get Beta Bionics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BBNX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners